Diabetes mellitus as a risk factor of liver cirrhosis in patients with chronic hepatitis B virus infection

被引:37
作者
Huo, TI
Wu, JC [1 ]
Lee, PC
Tsay, SH
Chang, FY
Lee, SD
机构
[1] Taipei Vet Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan
[3] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan
关键词
diabetes mellitus; hepatitis B virus; superinfection; chronic hepatitis; liver cirrhosis;
D O I
10.1097/00004836-200004000-00009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver cirrhosis may occur in chronic hepatitis B surface antigen (HBsAg) carriers. Diabetes mellitus (DM)-associated chronic hepatitis may also occasionally lead to cirrhosis; however, its role in the course of chronic HBsAg carriers has not been studied. A cohort of 500 HBsAg carriers (398 men; mean age at entry, 42 +/- 15 years) were followed up longitudinally. After a mean follow-up of 5.8 +/- 3.3 years, 71 (14.2%; 70 men) patients developed cirrhosis. Increased risks of cirrhosis were found among men and the elderly (p < 0.001). Fifteen (21.1%) cirrhotic patients were noted to have had DM for 2-15 years before the development of cirrhosis. By contrast, only eight (1.9%; p < 0.001) of the patients without cirrhosis developed DM. When cirrhotic patients were compared to 102 age- and sex-matched non-cirrhotic controls, DM and elevation of serum alanine transaminase levels were found to be independent factors associated with the advent of cirrhosis in multivariate analysis. Other factors, including acute exacerbation, bridging hepatic necrosis, and superinfection by hepatitis C or D viruses, were insignificant. Our results suggest that DM may play a role in the progression to liver cirrhosis in chronic HBsAg carriers. High-risk subjects should be closely monitored for late complications.
引用
收藏
页码:250 / 254
页数:5
相关论文
共 34 条
[1]   THE PATHOLOGY OF DIABETIC HEPATITIS [J].
BALAZS, M .
JOURNAL OF PATHOLOGY, 1989, 159 (04) :351-352
[2]   PROGNOSTIC-SIGNIFICANCE OF DIABETES IN PATIENTS WITH CIRRHOSIS [J].
BIANCHI, G ;
MARCHESINI, G ;
ZOLI, M ;
BUGIANESI, E ;
FABBRI, A ;
PISI, E .
HEPATOLOGY, 1994, 20 (01) :119-125
[3]   A POPULATION SURVEY ON THE PREVALENCE OF DIABETES IN KIN-HU, KINMEN [J].
CHOU, PS ;
HSIAO, KJ ;
LIAO, MJ ;
TSAI, ST ;
KUO, HS .
DIABETES CARE, 1994, 17 (09) :1055-1058
[4]  
COOKSLEY WGE, 1986, HEPATOLOGY, V6, P345
[5]  
FALCHUK KR, 1980, GASTROENTEROLOGY, V78, P535
[6]   NATURAL-HISTORY AND PROGNOSTIC FACTORS FOR CHRONIC HEPATITIS TYPE-B [J].
FATTOVICH, G ;
BROLLO, L ;
GIUSTINA, G ;
NOVENTA, F ;
PONTISSO, P ;
ALBERTI, A ;
REALDI, G ;
RUOL, A .
GUT, 1991, 32 (03) :294-298
[7]  
HARRIS M, 1979, DIABETES, V28, P1039
[8]   SEROCONVERSION FROM HEPATITIS-B-E ANTIGEN TO ANTIBODY IN CHRONIC TYPE-B HEPATITIS [J].
HOOFNAGLE, JH ;
DUSHEIKO, GM ;
SEEFF, LB ;
JONES, EA ;
WAGGONER, JG ;
BALES, ZB .
ANNALS OF INTERNAL MEDICINE, 1981, 94 (06) :744-748
[9]   Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis [J].
Hourigan, LF ;
Macdonald, GA ;
Purdie, D ;
Whitehall, VLJ ;
Shorthouse, C ;
Clouston, A ;
Powell, EE .
HEPATOLOGY, 1999, 29 (04) :1215-1219
[10]   Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis [J].
Huo, TI ;
Wu, JC ;
Lee, PC ;
Chau, GY ;
Lui, WY ;
Tsay, SH ;
Ting, LT ;
Chang, FY ;
Lee, SD .
HEPATOLOGY, 1998, 28 (01) :231-236